罗氏股价因新药销售不佳而下跌——路透社
Roche shares fall as new drug sales disappoint - Reuters
生物技术与制药领域的最新动态
Roche shares fall as new drug sales disappoint - Reuters
10x Genomics and Prognosys Biosciences Allege Illumina Infringed Four Spatial Transcriptomics Patents - IPWatchdog.com
10x, Roche, Prognosys Sue Illumina over Spatial and Single-Cell Patents - GEN - Genetic Engineering and Biotechnology News
Thermo Fisher Scientific (TMO): Assessing Valuation After Upbeat Q3 Results and Raised Outlook - Yahoo Finance
Thermo Fisher Scientific Launches Industry-First Orbitrap Mass Detector for Environmental and Food Safety Testing - Business Wire
Compact Design, Big Impact: Tridek-One Therapeutics Leverages MyGlo® to Accelerate Discovery of Immunomodulating Treatments
10x Genomics sues Illumina, expanding high-profile patent assertions - IAM Patent
Lonza Reports Strong Q3 2025 and Confirms Full-Year Outlook - TipRanks
Lonza Delivers a Strong Q3 2025 and Confirms Full-Year 2025 Outlook for its CDMO and CHI Businesses - TradingView
Lonza confirms outlook as it expects more contracts in coming months - Reuters
Thermo Fisher's Q3 Earnings & Revenues Top Estimates, Stock Climbs - Yahoo Finance
Thermo Fisher Scientific Q3 Profit Beats Estimates - Nasdaq
Thermo Fisher Scientific Inc (TMO) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance
Thermo Fisher lifts annual forecasts on tools demand, recent deals - Reuters
Thermo Fisher Scientific Reports Third Quarter 2025 Results - Business Wire
Thermo Fisher Scientific beats Q3 expectations as revenue rises 5% - Investing.com
Thermo Fisher sales jump 5% in Q3 amid new launches, approvals - Fierce Biotech
Illumina faces patent lawsuits from 10x Genomics over gene sequencing tech - MSN
10x Genomics (TXG) Moves 11.1% Higher: Will This Strength Last? - Yahoo Finance
Lonza Receives Swissmedic Approval for Highly Potent Biologics Drug Product Filling Line in Stein (CH) - Technology Networks